Skip to main content

Phyllanthus emblica L. (Phyllanthaceae)

(Syns.: Emblica officinalis Gart.; E. arborea Raf.)

  • Chapter
  • First Online:
Handbook of 200 Medicinal Plants

Abstract

The fruits are used medicinally in both fresh and dried forms, and also preserved in syrup, in India. Ibn al-Baitar, referring to Avicenna, described it as one of the most astringent drugs and thus a very useful cardiotonic, and to improve memory. It is especially useful in diseases caused by black bile, quenches thirst, is aphrodisiac, and antiemetic. In its fresh form, Hindu physicians consider it refrigerant, diuretic and laxative; and the dried one as cooling, stomachic and astringent. Muslim practitioners of Unani medicine also regard it as astringent, refrigerant, cardiacal, and a purifier of body humours. It strengthens vital organs, stomach, and eyes, and is especially useful to improve memory, eyesight, relieves palpitation, and heart weakness. It is also used to treat stomach ‘weakness’ and diarrhea, and its use, both topically and systemically, helps strengthen hairs and to maintain their shine and color. In Ayurveda, it is one of the rasayana plants with adaptogenic property, and is used as a powerful rejuvenator. Fresh fruit pulp and the pericarp of dried mature fruits are used in raktapitta, amlapittaprameha, and dãha. It is one of the major constituent plants of polyherbal memory and vitality-enhancing medicines marketed in India. Seventeen countries in the world are reported to use various parts of P. emblica in their medical treatment for hepatitis, cancer, tumors, regulation of stomach function, as a traditional immunomodulator and a natural adaptogen. Aqueous fruit extracts show the presence of tannins, saponins, flavonoids, terpenoids and phenols. Gallic acid, ellagic acid, chebulinic acid, quercetin, chebulagic acid, corilagin, ellagitannins, phenolic constituents, bisabolane-type sesquiterpenoid, bisabolane sesquiterpenoid glycoside, phyllaemblic acid and glochicoccin D have been isolated from the fruits. Aqueous extract significantly attenuated behavioral, biochemical and molecular alterations, and in combination with insulin also reversed neuropathic pain in diabetic rats; and significantly inhibited rat lens and recombinant human aldose reductase, and tannoids fraction was 100 times more potent than the aqueous extract, comparable to or better than quercetin. Aqueous fruit extract also produced antidepressant-like effect in mice; whereas the hydroalcohol extract showed memory enhancing, antioxidant, and anti-AChE activity in scopolamine-induced cognitive impairment in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998;62:183–93.

    CAS  PubMed  Google Scholar 

  2. Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62:609–16.

    Google Scholar 

  3. Al-Rehaily AJ, Al-Howiriny TA, Al-Sohaibani MO, Rafatullah S. Gastroprotective effects of ‘Amla’ Emblica officinalis on in vivo test models in rats. Phytomedicine. 2002;9:515–22.

    CAS  PubMed  Google Scholar 

  4. Anila L, Vijayalakshmi NR. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res. 2000;14:592–5.

    CAS  PubMed  Google Scholar 

  5. Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica—effectiveness for dyslipidemia. J Ethnopharmacol. 2002;79:81–7.

    CAS  PubMed  Google Scholar 

  6. Antony B, Benny M, Kaimal TN. A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia. Indian J Clin Biochem. 2008;23:378–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn. leaf extracts. J Pharm Pharmacol. 1993;45:581–4.

    CAS  PubMed  Google Scholar 

  8. Augusti KT, Arathy SL, Asha R, et al. A comparative study on the beneficial effects of garlic (Allium sativum Linn), Amla (Emblica officinalis Gaertn.) and onion (Allium cepa Linn) on the hyperlipidemia induced by butter fat and beef fat in rats. Indian J Exp Biol. 2001;39:760–6.

    CAS  PubMed  Google Scholar 

  9. Bajpai M, Pande A, Tewari SK, Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr. 2005;56:287–91.

    CAS  PubMed  Google Scholar 

  10. Bandyopadhyay SK, Pakrashi SC, Pakrashi A. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol. 2000;70:171–6.

    CAS  PubMed  Google Scholar 

  11. Bhatia J, Tabassum F, Sharma AK, et al. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc Toxicol. 2011;11:272–9.

    PubMed  Google Scholar 

  12. Bhattachary SK, Bhattacharya D, Muruganandam AV. Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia. Indian J Exp Biol. 2000;38:945–7.

    CAS  PubMed  Google Scholar 

  13. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (Amla). Indian J Exp Biol. 1999;37:676–80.

    CAS  PubMed  Google Scholar 

  14. Bhattacharya A, Ghosal S, Bhattacharya SK. Antioxidant activity of tannoid principles of Emblica officinalis (Amla) in chronic stress induced changes in rat brain. Indian J Exp Biol. 2000;38:877–80.

    CAS  PubMed  Google Scholar 

  15. Bhattacharya A, Kumar M, Ghosal S, Bhattacharya SK. Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats. Phytomedicine. 2000;7:173–5.

    CAS  PubMed  Google Scholar 

  16. Bhattacharya S, Chaudhuri SR, Chattopadhyay S, Bandyopadhyay SK. Healing properties of some Indian medicinal plants against indomethacin-induced gastric ulceration of rats. J Clin Biochem Nutr. 2007;41:106–14.

    PubMed  PubMed Central  Google Scholar 

  17. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart. Phytomedicine. 2002;9:171–4.

    CAS  PubMed  Google Scholar 

  18. Chakraborty D, Verma R. Spermatotoxic effect of ochratoxin and its amelioration by Emblica officinalis aqueous extract. Acta Pol Pharm. 2009;66:689–95.

    PubMed  Google Scholar 

  19. Chatterjee A, Chattopadhyay S, Bandyopadhyay SK. Biphasic effect of Phyllanthus emblica L. extract on NSAID-induced ulcer: an antioxidative trail weaved with immunomodulatory effect. Evid Based Complement Alternat Med. 2011:146808.

    Google Scholar 

  20. Chaudhuri RK. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol. 2002;15:374–80.

    CAS  PubMed  Google Scholar 

  21. Chen KH, Lin BR, Chien CT, Ho CH. Emblica officinalis Gaertn. attentuates N-nitrosodiethylamine-induced apoptosis, autophagy, and inflammation in rat livers. J Med Food. 2011;14:746–55.

    Google Scholar 

  22. Chen TS, Liou SY, Chang YL. Antioxidant evaluation of three adaptogen extracts. Am J Chin Med. 2008;36:1209–17.

    CAS  PubMed  Google Scholar 

  23. Chen TS, Liou SY, Chang YL. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med. 2009;37:19–25.

    PubMed  Google Scholar 

  24. Chen TS, Liou SY, Wu HC, et al. Efficacy of epigallocatechin-3-gallate and Amla (Emblica officinalis) extract for the treatment of diabetic-uremic patients. J Med Food. 2011;14:718–23.

    CAS  PubMed  Google Scholar 

  25. Choudhary GP. Biodeterioration in Emblica based medicinal products and their aflatoxin contamination. Anc Sci Life. 2011;30:65–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Damodara Reddy V, Padmavathi P, Gopi S, et al. Protective effect of Emblica officinalis against alcohol-induced hepatic injury by ameliorating oxidative stress in rats. Indian J Clin Biochem. 2010;25:419–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. De A, De A, Papasian C, et al. Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors. PLoS ONE. 2013;8:e72748.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Deng R. A review of the hypoglycemic effects of five commonly used herbal food supplements. Recent Pat Food Nutr Agric. 2012;4:50–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Dhingra D, Joshi P, Gupta A, Chhillar R. Possible involvement of monoaminergic neurotransmission in antidepressant-like activity of Emblica officinalis fruits in mice. CNS Neurosci Ther. 2012;18:419–25.

    CAS  PubMed  Google Scholar 

  30. D’souza JJ, D’souza PP, Fazal F, et al. Antidiabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn.: active constituents and modes of action. Food Funct. 2014;5:635–44.

    Google Scholar 

  31. el-Mekkawy S, Meselhy MR, Kusumoto IT, et al. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo). 1995;43:641–8.

    Google Scholar 

  32. Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21:579–85.

    CAS  PubMed  Google Scholar 

  33. Fatima N, Pingali U, Pilli R. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects. Pharmacognosy Res. 2014;6:29–35.

    PubMed  PubMed Central  Google Scholar 

  34. Golechha M, Bhatia J, Arya DS. Hydroalcoholic extract of Emblica officinalis Gaertn. affords protection against PTZ-induced seizures, oxidative stress and cognitive impairment in rats. Indian J Exp Biol. 2010;48:474–8.

    Google Scholar 

  35. Golechha M, Bhatia J, Arya DS. Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice. J Environ Biol. 2012;33:95–100.

    PubMed  Google Scholar 

  36. Golechha M, Bhatia J, Ojha S, Arya DS. Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention. Pharm Biol. 2011;49:1128–36.

    PubMed  Google Scholar 

  37. Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012;44:238–42.

    PubMed  PubMed Central  Google Scholar 

  38. Gulati RK, Agarwal S, Agrawal SS. Hepatoprotective studies on Phyllanthus emblica Linn. and quercetin. Indian J Exp Biol. 1995;33:261–8.

    Google Scholar 

  39. Habib-ur-Rehman, Yasin KA, Choudhary MA, et al. Studies on the chemical constituents of Phyllanthus emblica. Nat Prod Res. 2007;21:775–81.

    Google Scholar 

  40. Haque R, Bin-Hafeez B, Ahmad I, et al. Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum Exp Toxicol. 2001;20:643–50.

    Google Scholar 

  41. Hari Kumar KB, Sabu MC, Lima PS, Kuttan R. Modulation of haematopoetic system and antioxidant enzymes by Emblica officinalis Gaertn. and its protective role against gamma-radiation induced damages in mice. J Radiat Res (Tokyo). 2004;45:549–55.

    CAS  Google Scholar 

  42. Hiraganahalli BD, Chinampudur VC, Dethe S, et al. Hepatoprotective and antioxidant activity of standardized herbal extracts. Pharmacogn Mag. 2012;8:116–23.

    PubMed  PubMed Central  Google Scholar 

  43. Huabprasert S, Kasetsinsombat K, Kangsadalampai K, et al. The Phyllanthus emblica L. infusion carries immunostimulatory activity in a mouse model. J Med Assoc Thai. 2012;95 Suppl 2:S75–82.

    Google Scholar 

  44. Ihantola-Vormisto A, Summanen J, Kankaanranta H, et al. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med. 1997;63:518–24.

    CAS  PubMed  Google Scholar 

  45. Jacob A, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (Amla) on serum cholesterol levels in men aged 35–55 years. Eur J Clin Nutr. 1988;42:939–44.

    CAS  PubMed  Google Scholar 

  46. Jagetia GC. Radioprotective potential of plants and herbs against the effects of ionizing radiation. J Clin Biochem Nutr. 2007;40:74–81.

    CAS  Google Scholar 

  47. Jain SK, Khurdiya DS. Vitamin C enrichment of fruit juice based ready-to-serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn.) juice. Plant Foods Hum Nutr. 2004;59:63–6.

    Google Scholar 

  48. Jeena KJ, Joy KL, Kuttan R. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett. 1999;136:11–6.

    CAS  PubMed  Google Scholar 

  49. Jindal A, Soyal D, Sharma A, Goyal PK. Protective effect of an extract of Emblica officinalis against radiation-induced damage in mice. Integr Cancer Ther. 2009;8:98–105.

    PubMed  Google Scholar 

  50. Jose JK, Kuttan G, Kuttan R. Antitumour activity of Emblica officinalis. J Ethnopharmacol. 2001;75:65–9.

    CAS  PubMed  Google Scholar 

  51. Jose JK, Kuttan R. Hepatoprotective activity of Emblica officinalis and Chyavanaprash. J Ethnopharmacol. 2000;72:135–40.

    CAS  PubMed  Google Scholar 

  52. Kalekar SA, Munshi RP, Thatte UM. Do plants mediate their antidiabetic effects through antioxidant and antiapoptotic actions? An in vitro assay of 3 Indian medicinal plants. BMC Complement Altern Med. 2013;13:257.

    PubMed  PubMed Central  Google Scholar 

  53. Kalekar SA, Munshi RP, Bhalerao SS, Thatte UM. Insulin sensitizing effect of 3 Indian medicinal plants: an in vitro study. Indian J Pharmacol. 2013;45:30–3.

    PubMed  PubMed Central  Google Scholar 

  54. Khan MT, Lampronti I, Martello D, et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol. 2002;21:187–92.

    CAS  PubMed  Google Scholar 

  55. Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18:415–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Kim HJ, Yokozawa T, Kim HY, et al. Influence of Amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo). 2005;51:413–8.

    Google Scholar 

  57. Kim HY, Okubo T, Juneja LR, Yokozawa T. The protective role of Amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br J Nutr. 2010;103:502–12.

    Google Scholar 

  58. Koshy SM, Bobby Z, Hariharan AP, Gopalakrishna SM. Amla (Emblica officinalis) extract is effective in preventing high fructose diet-induced insulin resistance and atherogenic dyslipidemic profile in ovariectomized female albino rats. Menopause. 2012;19:1146–55.

    PubMed  Google Scholar 

  59. Krishnaveni M, Mirunalini S. Chemopreventive efficacy of Phyllanthus emblica L. (Amla) fruit extract on 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis—a dose-response study. Environ Toxicol Pharmacol. 2012;34:801–10.

    Google Scholar 

  60. Kumar A, Tantry BA, Rahiman S, Gupta U. Comparative study of antimicrobial activity and phytochemical analysis of methanolic and aqueous extracts of the fruit of Emblica officinalis against pathogenic bacteria. J Tradit Chin Med. 2011;31:246–50.

    PubMed  Google Scholar 

  61. Kumar KCS, Müller K. Medicinal plants from Nepal; II. Evaluation as inhibitors of lipid peroxidation in biological membranes. J Ethnopharmacol. 1999;64:135–9.

    Google Scholar 

  62. Kumar NP, Annamalai AR, Thakur RS. Antinociceptive property of Emblica officinalis Gaertn. (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats. Indian J Exp Biol. 2009;47:737–42.

    PubMed  Google Scholar 

  63. Kumaran A, Karunakaran RJ. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr. 2006;61:1–5.

    CAS  PubMed  Google Scholar 

  64. Lambertini E, Piva R, Khan MT, et al. Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Oncol. 2004;24:419–23.

    PubMed  Google Scholar 

  65. Lee CY, Peng WH, Cheng HY, et al. Hepatoprotective effect of Phyllanthus in Taiwan on acute liver damage induced by carbon tetrachloride. Am J Chin Med. 2006;34:471–82.

    PubMed  Google Scholar 

  66. Li B, Huang GQ, Lu RM, Wei JH, Zhong ZG. Study on chemical composition of Phyllanthus emblica. Zhong Yao Cai. 2015;38:290–3 (Chinese).

    Google Scholar 

  67. Lv JJ, Wang YF, Zhang JM, et al. Antihepatitis B virus activities and absolute configurations of sesquiterpenoid glycosides from Phyllanthus emblica. Org Biomol Chem. 2014;12:8764–74.

    CAS  PubMed  Google Scholar 

  68. Mahata S, Pandey A, Shukla S, et al. Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutr Cancer. 2013;65 Suppl 1:88–97.

    Google Scholar 

  69. Majeed M, Bhat B, Jadhav AN, et al. Ascorbic acid and tannins from Emblica officinalis Gaertn. fruits. A Revisit. J Agric Food Chem. 2009;57:220–5.

    Google Scholar 

  70. Mathur R, Sharma A, Dixit VP, Varma M. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol. 1996;50:61–8.

    CAS  PubMed  Google Scholar 

  71. Menon LG, Kuttan R, Kuttan G. Effect of rasayanas in the inhibition of lung metastasis induced by B16F-10 melanoma cells. J Exp Clin Cancer Res. 1997;16:365–8.

    CAS  PubMed  Google Scholar 

  72. Mir AI, Kumar B, Tasduq SA, et al. Reversal of hepatotoxin-induced prefibrogenic events by Emblica officinalis—a histological study. Indian J Exp Biol. 2007;45:626–9.

    CAS  PubMed  Google Scholar 

  73. Mishra M, Pathak UN, Khan AB. Emblica officinalis Gaertn. and serum cholesterol level in experimental rabbits. Br J Exp Pathol. 1981;62:526–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. Muruganandam AV, Kumar V, Bhattacharya SK. Effect of polyherbal formulation, EuMil, on chronic stress-induced homeostatic perturbations in rats. Indian J Exp Biol. 2002;40:1151–60.

    CAS  PubMed  Google Scholar 

  75. Muthuraman A, Sood S, Singla SK. The anti-inflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology. 2011;19:327–34.

    Google Scholar 

  76. Nain P, Saini V, Sharma S, Nain J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol. 2012;142:65–71.

    Google Scholar 

  77. Nakanishi K, Sasaki S, Kiang AK, et al. Phytochemical survey of Malaysian plants preliminary chemical and pharmacological screening. Chem Pharm Bull (Tokyo). 1965;13:882–90.

    CAS  Google Scholar 

  78. Nampoothiri SV, Prathapan A, Cherian OL, et al. In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem Toxicol. 2011;49:125–31.

    CAS  PubMed  Google Scholar 

  79. Ngamkitidechakul C, Jaijoy K, Hansakul P, et al. Antitumour effects of Phyllanthus emblica L.: induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother Res. 2010;24:1405–13.

    Google Scholar 

  80. Nicolis E, Lampronti I, Dechecchi MC, et al. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of proinflammatory genes in bronchial epithelial cells. Int Immunopharmacol. 2008;8:1672–80.

    CAS  PubMed  Google Scholar 

  81. Ojha S, Golechha M, Kumari S, Arya DS. Protective effect of Emblica officinalis (Amla) on isoproterenol-induced cardiotoxicity in rats. Toxicol Ind Health. 2012;28:399–411.

    CAS  PubMed  Google Scholar 

  82. Panchabhai TS, Ambarkhane SV, Joshi AS, et al. Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study. Phytother Res. 2008;22:646–50 (Erratum in: Phytother Res. 2008;22:1274).

    Google Scholar 

  83. Panda S, Kar A. Fruit extract of Emblica officinalis ameliorates hyperthyroidism and hepatic lipid peroxidation in mice. Pharmazie. 2003;58:753–5.

    CAS  PubMed  Google Scholar 

  84. Patel SS, Goyal RK. Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Exp Clin Cardiol. 2011;16:87–91.

    PubMed  PubMed Central  Google Scholar 

  85. Perianayagam JB, Sharma SK, Joseph A, Christina AJ. Evaluation of antipyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol. 2004;95:83–5.

    PubMed  Google Scholar 

  86. Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, et al. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol. 2008;14:1491–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Pinmai K, Hiriote W, Soonthornchareonnon N, et al. In vitro and in vivo antiplasmodial activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula, and Terminalia bellerica. J Med Assoc Thai. 2010;93 Suppl 7:S120–6.

    Google Scholar 

  88. Pozharitskaya ON, Ivanova SA, Shikov AN, Makarov VG. Separation and evaluation of free radical-scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC-DPPH* method. J Sep Sci. 2007;30:1250–4.

    CAS  PubMed  Google Scholar 

  89. Prajapati VK, Nema PK, Rathore SS. Effect of pretreatment and drying methods on quality of value-added dried aonla (Emblica officinalis Gaertn.) shreds. J Food Sci Technol. 2011;48:45–52.

    CAS  PubMed  Google Scholar 

  90. Pramyothin P, Samosorn P, Poungshompoo S, Chaichantipyuth C. The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury. J Ethnopharmacol. 2006;107:361–4.

    Google Scholar 

  91. Puppala M, Ponder J, Suryanarayana P, et al. The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. PLoS ONE. 2012;7:e31399.

    CAS  PubMed  PubMed Central  Google Scholar 

  92. Rahmatullah M, Azam MN, Khatun Z, et al. Medicinal plants used for treatment of diabetes by the Marakh sect of the Garo tribe living in Mymensingh district, Bangladesh. Afr J Tradit Complement Altern Med. 2012;9:380–5.

    PubMed  PubMed Central  Google Scholar 

  93. Rajak S, Banerjee SK, Sood S, et al. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res. 2004;18:54–60.

    CAS  PubMed  Google Scholar 

  94. Rajeshkumar NV, Pillai MR, Kuttan R. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res. 2003;22:201–12.

    CAS  PubMed  Google Scholar 

  95. Rao TP, Sakaguchi N, Juneja LR, et al. Amla (Emblica officinalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food. 2005;8:362–8.

    Google Scholar 

  96. Reddy VD, Padmavathi P, Kavitha G, et al. Emblica officinalis ameliorates alcohol-induced brain mitochondrial dysfunction in rats. J Med Food. 2011;14:62–8.

    PubMed  Google Scholar 

  97. Reddy VD, Padmavathi P, Paramahamsa M, Varadacharyulu NC. Amelioration of alcohol-induced oxidative stress by Emblica officinalis (Amla) in rats. Indian J Biochem Biophys. 2010;47:20–5.

    CAS  PubMed  Google Scholar 

  98. Reddy VD, Padmavathi P, Varadacharyulu NCh. Emblica officinalis protects against alcohol-induced liver mitochondrial dysfunction in rats. J Med Food. 2009;12:327–33.

    CAS  PubMed  Google Scholar 

  99. Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res. 1999;13:275–91.

    CAS  PubMed  Google Scholar 

  100. Sabu MC, Kuttan R. Antidiabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81:155–60.

    CAS  PubMed  Google Scholar 

  101. Saeed S, Tariq P. Antibacterial activities of Emblica officinalis and Coriandrum sativum against Gram negative urinary pathogens. Pak J Pharm Sci. 2007;20:32–5.

    PubMed  Google Scholar 

  102. Saini A, Sharma S, Chhibber S. Protective efficacy of Emblica officinalis against Klebsiella pneumoniae induced pneumonia in mice. Indian J Med Res. 2008;128:188–93.

    CAS  PubMed  Google Scholar 

  103. Sairam K, Rao ChV, Babu MD, et al. Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study. J Ethnopharmacol. 2002;82:1–9.

    CAS  PubMed  Google Scholar 

  104. Saito K, Kohno M, Yoshizaki F, Niwano Y. Extensive screening for edible herbal extracts with potent scavenging activity against superoxide anions. Plant Foods Hum Nutr. 2008;63:65–70.

    PubMed  Google Scholar 

  105. Sancheti G, Jindal A, Kumari R, Goyal PK. Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev. 2005;6:197–201.

    PubMed  Google Scholar 

  106. Sarkar R, Hazra B, Mandal N. Amelioration of iron overload-induced liver toxicity by a potent antioxidant and iron chelator Emblica officinalis Gaertn. Toxicol Ind Health. 2015;31:656–69.

    CAS  PubMed  Google Scholar 

  107. Sarkar R, Mandal N. Hydroalcoholic extracts of Indian medicinal plants can help in amelioration from oxidative stress through antioxidant properties. J Complement Integr Med. 2012;9:Article 7.

    Google Scholar 

  108. Shah JS, Goyal RK. Usage trends for memory and vitality-enhancing medicines: a pharmacoepidemiological study involving pharmacists of the Gujarat region. Int J Ayurveda Res. 2010;1:138–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  109. Sharma A, Sharma MK, Kumar M. Modulatory role of Emblica officinalis fruit extract against arsenic induced oxidative stress in Swiss albino mice. Chem Biol Interact. 2009;180:20–30.

    CAS  PubMed  Google Scholar 

  110. She G, Cheng R, Sha L, et al. A novel phenolic compound from Phyllanthus emblica. Nat Prod Commun. 2013;8:461–2.

    CAS  PubMed  Google Scholar 

  111. Shukla V, Vashistha M, Singh SN. Evaluation of antioxidant profile and activity of amalaki (Emblica officinalis), spirulina and wheat grass. Indian J Clin Biochem. 2009;24:70–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  112. Sidhu S, Pandhi P, Malhotra S, et al. Beneficial effects of Emblica officinalis in l-arginine-induced acute pancreatitis in rats. J Med Food. 2011;14:147–55.

    CAS  PubMed  Google Scholar 

  113. Singh I, Sharma A, Nunia V, Goyal PK. Radioprotection of Swiss albino mice by Emblica officinalis. Phytother Res. 2005;19:444–6.

    PubMed  Google Scholar 

  114. Singh I, Soyal D, Goyal PK. Emblica officinalis (Linn.) fruit extract provides protection against radiation-induced hematological and biochemical alterations in mice. J Environ Pathol Toxicol Oncol. 2006;25:643–54.

    Google Scholar 

  115. Sultana S, Ahmad S, Khan N, Jahangir T. Effect of Emblica officinalis (Gaertn.) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J Exp Biol. 2005;43:430–6.

    PubMed  Google Scholar 

  116. Sultana S, Ahmed S, Jahangir T. Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats. J Ethnopharmacol. 2008;118:1–6.

    PubMed  Google Scholar 

  117. Sultana S, Ahmed S, Sharma S, Jahangir T. Emblica officinalis reverses thioacetamide-induced oxidative stress and early promotional events of primary hepatocarcinogenesis. J Pharm Pharmacol. 2004;56:1573–9.

    CAS  PubMed  Google Scholar 

  118. Sumantran VN, Kulkarni A, Chandwaskar R, et al. Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis. Evid Based Complement Alternat Med. 2008;5:329–35.

    PubMed  Google Scholar 

  119. Suresh K, Vasudevan DM. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol. 1994;44:55–60.

    CAS  PubMed  Google Scholar 

  120. Suryanarayana P, Kumar PA, Saraswat M, et al. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis. 2004;10:148–54.

    CAS  PubMed  Google Scholar 

  121. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis. 2007;13:1291–7.

    CAS  PubMed  Google Scholar 

  122. Tasanarong A, Kongkham S, Itharat A. Antioxidant effect of Phyllanthus emblica extract prevents contrast-induced acute kidney injury. BMC Complement Altern Med. 2014;14:138.

    PubMed  PubMed Central  Google Scholar 

  123. Tasduq SA, Kaisar P, Gupta DK, et al. Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against antituberculosis drugs induced liver toxicity. Phytother Res. 2005;19:193–7.

    CAS  PubMed  Google Scholar 

  124. Tasduq SA, Mondhe DM, Gupta DK, Baleshwar M, Johri RK. Reversal of fibrogenic events in liver by Emblica officinalis (fruit), an Indian natural drug. Biol Pharm Bull. 2005;28:1304–6.

    CAS  PubMed  Google Scholar 

  125. Thakur CP, Mandal K. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits. Indian J Med Res Sect A—Infect Dis. 1984;79:142–6.

    CAS  Google Scholar 

  126. Thakur CP, Thakur B, Singh S, et al. The ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol. 1988;21:167–75.

    CAS  PubMed  Google Scholar 

  127. Thakur CP. Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia. 1985;41:423–4.

    CAS  PubMed  Google Scholar 

  128. Thirunavukkarasu M, Selvaraju V, Tapias L, et al. Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway. J Physiol Biochem. 2015;71:623–33.

    PubMed  Google Scholar 

  129. Thorat SP, Rege NN, Naik AS, et al. Emblica officinalis: a novel therapy for acute pancreatitis—an experimental study. HPB Surg. 1995;9:25–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  130. Tiwari V, Kuhad A, Chopra K. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxidonitrosative stress mediated inflammatory cascade. Phytother Res. 2011;25:1527–36.

    PubMed  Google Scholar 

  131. Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013;6:275–84.

    PubMed  PubMed Central  Google Scholar 

  132. Vasant RA, Narasimhacharya AV. Amla as an antihyperglycemic and hepatorenal protective agent in fluoride induced toxicity. J Pharm Bioallied Sci. 2012;4:250–4.

    PubMed  PubMed Central  Google Scholar 

  133. Verma R, Chakraborty D. Alterations in DNA, RNA and protein contents in liver and kidney of mice treated with ochratoxin and their amelioration by Emblica officinalis aqueous extract. Acta Pol Pharm. 2008;65:3–9.

    CAS  PubMed  Google Scholar 

  134. Verma R, Chakraborty D. Emblica officinalis aqueous extract ameliorates ochratoxin-induced lipid peroxidation in the testis of mice. Acta Pol Pharm. 2008;65:187–94.

    CAS  PubMed  Google Scholar 

  135. Vijayalakshmi S, Arunkumar V, Anju D, et al. Comparative antimicrobial activities of Emblica officinalis and Ocimum sanctum. Anc Sci Life. 2007;27:1–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  136. Waheed S, Fatima I. Instrumental neutron activation analysis of Emblica officinalis, Terminalia belerica and Terminalia chebula for trace element efficacy and safety. Appl Radiat Isot. 2013;77:139–44.

    CAS  PubMed  Google Scholar 

  137. Xia Q, Xiao P, Wan L, Kong J. Ethnopharmacology of Phyllanthus emblica L.]. Zhongguo Zhong Yao Za Zhi. 1997;22:515–8, 525, 574 (Chinese).

    Google Scholar 

  138. Xiang Y, Pei Y, Qu C, et al. In vitro antiherpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-β-d-glucose from Phyllanthus emblica L. (Euphorbiaceae). Phytother Res. 2011;25:975–82.

    Google Scholar 

  139. Yahayo W, Supabphol A, Supabphol R. Suppression of human fibrosarcoma cell metastasis by Phyllanthus emblica extract in vitro. Asian Pac J Cancer Prev. 2013;14:6863–7.

    PubMed  Google Scholar 

  140. Yokozawa T, Kim HY, Kim HJ, et al. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr. 2007;97:1187–95.

    Google Scholar 

  141. Yokozawa T, Kim HY, Kim HJ, et al. Amla (Emblica officinalis Gaertn.) attenuates age-related renal dysfunction by oxidative stress. J Agric Food Chem. 2007;55:7744–52.

    Google Scholar 

  142. Zhang LZ, Zhao WH, Guo YJ, et al. Studies on chemical constituents in fruits of Tibetan medicine Phyllanthus emblica. Zhongguo Zhong Yao Za Zhi. 2003;28:940–3 (Chinese).

    Google Scholar 

  143. Zhang Y, Zhao L, Guo X, et al. Chemical constituents from Phyllanthus emblica and the cytoprotective effects on H2O2-induced PC12 cell injuries. Arch Pharm Res. 2016;39:1202–11.

    CAS  PubMed  Google Scholar 

  144. Zhang YJ, Abe T, Tanaka T, et al. Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J Nat Prod. 2001;64:1527–32.

    CAS  PubMed  Google Scholar 

  145. Zhang YJ, Tanaka T, Yang CR, Kouno I. New phenolic constituents from the fruit juice of Phyllanthus emblica. Chem Pharm Bull (Tokyo). 2001;49:537–40.

    CAS  Google Scholar 

  146. Zhao T, Sun Q, Marques M, Witcher M. Anticancer properties of Phyllanthus emblica (Indian Gooseberry). Oxid Med Cell Longev. 2015;2015:950890.

    PubMed  PubMed Central  Google Scholar 

  147. Zhu X, Wang J, Ou Y, Han W, Li H. Polyphenol extract of Phyllanthus emblica (PEEP) induces inhibition of cell proliferation and triggers apoptosis in cervical cancer cells. Eur J Med Res. 2013;18:46.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahid Akbar .

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Akbar, S. (2020). Phyllanthus emblica L. (Phyllanthaceae). In: Handbook of 200 Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-030-16807-0_144

Download citation

Publish with us

Policies and ethics